Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders [NA]

View source ↗

Summary

Phase 1 clinical trial update for Gustabor exploring an AI-driven nutritional plan to compensate for chemotherapy-induced taste disorders in patients with multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Multiple Myeloma, GI Cancer | NA | Status: NOT_YET_RECRUITING